


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-1.66%
+0.84%
+1.28%
-0.09%
RVMD
Revolution Medicines Inc.
$67.75
Strengths

Upgraded on attractively valued

Outperform the market
Chart
$54.01 (+25.44%)
$37.01 (+83.06%)
$37.48 (+80.76%)
$57.85 (+17.11%)
RVMD has Moderate risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

RVMD overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate

Loss widens YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Outperform the market
![]()
RVMD Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
RVMD Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is RVMD current stock price?
What are RVMD stock strengths?
What is RVMD Risk Level?
What is RVMD market cap and volume?
What is RVMD current Stock IQ?
Should I buy RVMD stock right now?
Is RVMD a Strong Buy right now?
What does a 'Strong Buy' rating mean for RVMD?
What does a 'Strong Sell' rating mean for RVMD?
What factors influence RVMD's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-1.66%
+0.84%
+1.28%
-0.09%
RVMD
Revolution Medicines Inc.
Current Price
$67.75
Stock Insights
Strengths

Upgraded on attractively valued

Outperform the market

Chart
$54.01 (+25.44%)
$37.01 (+83.06%)
$37.48 (+80.76%)
$57.85 (+17.11%)
RVMD Analysts Opinion
RVMD Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Below analyst estimate

Loss widens YoY
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Outperform the market
![]()
RVMD Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
RVMD Street Sentiment is extremely bullish and have positive views on the near-term outlook
RVMD has Moderate risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

Average key support and resistance price levels.
RVMD Latest Analysis
KRAS Inhibitors Market to Witness Explosive Growth at a CAGR of 35% During the Forecast Period (2025–2034) Amid Expanding Therapeutic Landscape | DelveInsight. KRAS Inhibitors Market to Witness Explosive Growth at a CAGR of 35% During the Forecast Period (2025–2034) Amid Expanding Therapeutic Landscape |. DelveInsightThe KRAS inhibitors market is expected to experience substantial growth driven by rising cancer incidence improved treatment access and a robust pipeline including Olomorasib (E
Wed Nov 12, 2025
Revolution Medicines Inc. (RVMD) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript.
Tue Nov 11, 2025
JP Morgan Maintains Revolution Medicines (RVMD) Overweight Recommendation. Fintel reports that on November 6 2025 JP Morgan maintained coverage of Revolution Medicines (NasdaqGS:RVMD) with a Overweight recommendation. Analyst Price Forecast Suggests 28.88% Upside
Fri Nov 7, 2025
HC Wainwright & Co. Maintains Revolution Medicines (RVMD) Buy Recommendation. Fintel reports that on November 6 2025 HC Wainwright &. Co. maintained coverage of Revolution Medicines (NasdaqGS:RVMD) with a Buy recommendation. Analyst Price Forecast Suggests 33.31% Upside
Thu Nov 6, 2025
Needham Maintains Revolution Medicines (RVMD) Buy Recommendation. Fintel reports that on November 6 2025 Needham maintained coverage of Revolution Medicines (NasdaqGS:RVMD) with a Buy recommendation. Analyst Price Forecast Suggests 33.31% Upside
Thu Nov 6, 2025
Wedbush Maintains Revolution Medicines (RVMD) Outperform Recommendation. Fintel reports that on November 6 2025 Wedbush maintained coverage of Revolution Medicines (NasdaqGS:RVMD) with a Outperform recommendation. Analyst Price Forecast Suggests 33.31% Upside
Thu Nov 6, 2025
Revolution Medicines Posts Wider-Than-Expected Loss in Q3 Sales Nil. RVMD posts a wider Q3 loss as rising R&D and administrative costs weigh while its RAS(ON) pipeline advances toward key 2026 data.
Thu Nov 6, 2025
Revolution Medicines outlines multiple Phase III trial launches and commercial buildout amid increased R&D investment.
Wed Nov 5, 2025
Revolution Medicines GAAP EPS of -$1.61 misses by $0.19.
Wed Nov 5, 2025
Revolution Medicines to Participate in November 2025 Investor Conferences. ) a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers today announced that Mark A. Goldsmith M.D. Ph.D. the company'.s chief executive officer and chairman will participate in two upcoming investor conferences.Fireside Chat: Tuesday November 11 at 9:00 a.m. ET
Tue Nov 4, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
RVMD Stock trends
RVMD Stock performance
RVMD Stock analysis
RVMD investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.